Balance Medical(SH:688198) Ge Long Hui A P P·2025-12-11 08:38Core Viewpoint - The approval of the collagen implant product by the National Medical Products Administration marks a significant advancement for the company, as it is the first collagen product in China designed for injection into the dermis of the cheeks to improve skin smoothness [1] Group 1: Product Details - The product is a natural cross-linked complete type I collagen fiber (Collagen Fibrils & Fibers) with a stable triple helix structure, which self-assembles into an ordered fibrous supramolecular structure [1] - The implantation of this product can supplement the collagen framework in the dermis of the cheeks, improving extracellular matrix metabolism and enhancing skin texture and elasticity [1] - The innovative technology includes a proprietary ultra-pure extraction process and precise peptide cleavage to ensure the amino acid sequence and composition are consistent with human type I collagen at the molecular level [1] Group 2: Clinical Validation - Clinical trials have confirmed that the product has no difference in immunogenicity compared to natural human collagen [1] - The full-length collagen molecule ensures the integrity of its triple helix structure, while high purity allows for self-assembly into collagen fibers, distinguishing this product from previous similar injectable collagen products [1]